Fagan Charles Todd
Transaction: 08/11/2026
OTHER
Change
0
Price
Not reported
Filing
08/17/2026
Type
OTHER


Quantitative profile — not an investment recommendation.
Key valuation, quality, financial strength, momentum and analyst data.
How strong this company looks for long-term investors
Recent executive and insider activity
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Fagan Charles Todd | OTHER | 0 | Not reported | 08/11/2026 | 08/17/2026 |
| Voss Chelsea Sierra | BUY | +1,753 | $3.15 | 03/30/2026 | 05/14/2026 |
| Bernstein Bruce | BUY | +50,000 | $5.00 | 04/13/2026 | 04/15/2026 |
| Silverman Joshua | BUY | +100,000 | $5.00 | 04/13/2026 | 04/15/2026 |
| Silverman Joshua | BUY | +162,162 | Not reported | 04/13/2026 | 04/15/2026 |
| White Billy Joe | BUY | +50,000 | $5.00 | 04/13/2026 | 04/15/2026 |
| Glass Mitchell | BUY | +50,000 | $5.00 | 04/13/2026 | 04/15/2026 |
| Friscia Stephen | BUY | +50,000 | $5.00 | 04/13/2026 | 04/15/2026 |
| Voss Chelsea Sierra | BUY | +50,000 | $5.00 | 04/13/2026 | 04/15/2026 |
| Voss Chelsea Sierra | BUY | +212,500 | $5.10 | 01/16/2026 | 01/30/2026 |
| Voss Chelsea Sierra | OTHER | 0 | Not reported | 01/16/2026 | 01/30/2026 |
| PharmaCyte Biotech, Inc. | BUY | +889,865 | Not reported | 11/14/2025 | 11/18/2025 |
| PharmaCyte Biotech, Inc. | BUY | +889,865 | Not reported | 09/04/2025 | 11/18/2025 |
| White Billy Joe | BUY | +22,839 | Not reported | 11/14/2025 | 11/17/2025 |
| Glass Mitchell | BUY | +11,420 | Not reported | 11/14/2025 | 11/17/2025 |
| RAUCH GARY M | BUY | +11,420 | Not reported | 11/14/2025 | 11/14/2025 |
| Bernstein Bruce | BUY | +25,000 | Not reported | 11/14/2025 | 11/14/2025 |
| Friscia Stephen | BUY | +22,839 | Not reported | 11/14/2025 | 11/14/2025 |
| Silverman Joshua | BUY | +91,356 | Not reported | 11/14/2025 | 11/14/2025 |
| RAUCH GARY M | BUY | +1,080 | Not reported | 10/03/2025 | 10/06/2025 |